FTH surges 72% after EPS revision; RFIL, WDC, OTLK also gain on earnings and catalysts
Faeth Therapeutics (FTH) jumped 72.1% from $14.53 to $25.00 after its forward EPS growth estimate was raised to 93.7%. Americas Car Mart (CRMT) gained 61.1% with a 101.7% EPS growth estimate, while RF Industries (RFIL) rose 32.2% on strong Q2 results. Western Digital (WDC) climbed 17.7% on AI demand, and Outlook Therapeutics (OTLK) added 17.2% after FDA accepted its BLA resubmission.
| Ticker | Sector | Detected | EPS Revision | Gain Since Detection |
|---|---|---|---|---|
| FTH | Healthcare | 2026-06-16 | N/A | +72.1% |
| CRMT | Consumer Cyclical | 2026-06-16 | N/A | +61.1% |
| RFIL | Industrials | 2026-06-16 | N/A | +32.2% |
| WDC | Technology | 2026-06-14 | N/A | +17.7% |
| OTLK | Healthcare | 2026-06-16 | N/A | +17.2% |
Why did FTH stock jump in June 2026?
FTH jumped 72.1% (from $14.53 to $25.00) after analysts raised its forward EPS growth estimate to 93.7% on June 16.
The revision signaled a dramatic earnings turnaround, attracting buyers even though no specific earnings news followed. Healthcare sector momentum and the magnitude of the estimate increase likely amplified the move.
FTH EPS revision history → · Screener snapshot from 2026-06-16 →
FAQ: FTH
Why did FTH stock jump in June 2026?
FTH surged 72.1% from $14.53 to $25.00 after its forward EPS growth estimate was revised upward to 93.7% on June 16.
Is FTH a buy after the rally?
The 93.7% EPS growth estimate supports the rally, but with no earnings news, investors should monitor upcoming quarterly results for confirmation.
What is FTH's EPS growth estimate?
FTH's current EPS growth next year is 93.7%, revised upward on June 16, 2026.
Why did CRMT stock jump in June 2026?
CRMT jumped 61.1% (from $2.34 to $3.77) after analysts raised its forward EPS growth estimate to 101.7% on June 16.
The Consumer Cyclical sector saw renewed interest as the revision implied a sharp earnings recovery. No earnings news emerged, leaving the estimate revision as the primary catalyst.
CRMT EPS revision history → · Screener snapshot from 2026-06-16 →
FAQ: CRMT
Why did CRMT stock jump in June 2026?
CRMT surged 61.1% from $2.34 to $3.77 after its forward EPS growth estimate was raised to 101.7% on June 16.
What caused CRMT's surge?
The surge was driven by an upward EPS revision to 101.7% growth, with no additional earnings news in the window.
Is CRMT a buy after the rally?
The 101.7% EPS growth estimate is compelling, but lack of news warrants caution; further fundamental checks are needed.
Why did RFIL stock jump in June 2026?
RFIL jumped 32.2% (from $16.44 to $21.73) after analysts raised its forward EPS growth estimate to 29.0% on June 16, reinforced by strong Q2 results reported the same day.
Revenue rose 9% to $20.7 million, gross margin expanded 360 bps to 35.1%, and net income turned positive at $879,000. The combination of an upward revision and solid earnings beat drove the rally.
RFIL EPS revision history → · Screener snapshot from 2026-06-16 →
FAQ: RFIL
Why did RFIL stock jump in June 2026?
RFIL rose 32.2% after its EPS growth estimate was revised to 29.0% and Q2 earnings showed a net income swing to $879,000.
What caused RFIL's surge?
The surge was fueled by an upward EPS revision and a strong Q2 report with 9% revenue growth and margin expansion.
What is RFIL's EPS growth estimate?
RFIL's current EPS growth next year is 29.0%, revised upward on June 16, 2026.
Why did WDC stock jump in June 2026?
WDC jumped 17.7% (from $562.92 to $662.50) after analysts raised its forward EPS growth estimate to 77.2% on June 14, with subsequent catalysts including a strong Q3 earnings report on June 17 that showed revenue up 45% to $3.3 billion and EPS nearly doubling to $2.72.
AI and cloud demand, plus positive sector momentum from SK Hynix hitting a record market cap, reinforced the estimate-driven gain.
WDC EPS revision history → · Screener snapshot from 2026-06-14 →
FAQ: WDC
Why did WDC stock jump in June 2026?
WDC rose 17.7% after its EPS growth estimate was revised to 77.2% on June 14, followed by a Q3 earnings beat and AI-driven sector tailwinds.
What caused WDC's surge?
The combination of an upward EPS revision, strong Q3 earnings (revenue +45%, EPS nearly doubled), and booming memory chip demand drove the surge.
What is WDC's EPS growth estimate?
WDC's current EPS growth next year is 77.2%, revised upward on June 14, 2026.
Why did OTLK stock jump in June 2026?
OTLK jumped 17.2% (from $1.57 to $1.84) after analysts raised its forward EPS growth estimate to 53.3% on June 16, coinciding with FDA acceptance of its resubmitted BLA for wet AMD treatment ONS-5010 with a PDUFA date of July 29, 2026.
The regulatory catalyst validated the earnings turnaround narrative, pushing the stock higher.
OTLK EPS revision history → · Screener snapshot from 2026-06-16 →
FAQ: OTLK
Why did OTLK stock jump in June 2026?
OTLK rose 17.2% after its EPS growth estimate was revised to 53.3% and the FDA accepted its BLA resubmission for wet AMD treatment.
What caused OTLK's surge?
The surge was driven by an upward EPS revision and FDA acceptance of the BLA for ONS-5010 with a July 29 PDUFA date.
Is OTLK a buy after the rally?
The 53.3% EPS growth estimate and potential FDA approval in July provide upside, but regulatory risk remains until the PDUFA date.
Today's top performers show investors rewarding companies with upward EPS revisions, especially those confirmed by earnings beats (RFIL, WDC) or regulatory catalysts (OTLK). The moves reflect a risk-on sentiment focused on growth and turnaround stories across healthcare and tech sectors.
How We Identify These Stocks
We track daily changes in forward EPS estimates across thousands of US equities. When a stock's next-year earnings growth estimate is revised upward — confirmed by improvement in current-year estimates — it enters our watchlist. The stocks above were flagged on their detection dates and have since delivered the strongest price returns among all detected stocks.
Explore today's full screener →